REQUEST A DEMO
Total
USD $0.00
Search more companies

Alborz Darou Pharmaceutical Company Public Joint Stock (Iran)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Alborz Darou Pharmaceutical Company Public Joint Stock Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Alborz Darou Pharmaceutical is an Iranian pharmaceutical company specialized in the development, production and marketing of finished dosage forms. It offers ampoules, tablets, suspensions, syrups, capsules and prefilled syringes. The company was founded in 1976 under the name Tolipharma Co. and changed its name in 1989. Alborz Darou headquarters are in Tehran.

Legal Address
Africa Blvd Not Reaching To Crossroad Jahaan Koodak, Navak Street - No. 3, Floor 5
Tehran; Tehran; Postal Code: 1518646177

Contact Details: Purchase the Alborz Darou Pharmaceutical Company Public Joint Stock report to view the information.

Website: http://www.alborzdarouco.com

Basic Information
Total Employees:
Purchase the Alborz Darou Pharmaceutical Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Alborz Darou Pharmaceutical Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Alborz Darou Pharmaceutical Company Public Joint Stock report to view the information.
Incorporation Date:
1976
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
68.7%
Purchase this report to view the information.
6.4%
Purchase this report to view the information.
3.1%
Purchase this report to view the information.
2.8%
Purchase this report to view the information.
Subsidiaries
Pakhsh Alborz Company Public Joint Stock
15%
Etela Alborz Investment Company Public Joint Stock
1%
Kbc Company Public Joint Stock
0.02%
Company Performance
Financial values in the chart are available after Alborz Darou Pharmaceutical Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
47.29%
Total operating revenue
47.59%
Operating profit (EBIT)
55.4%
EBITDA
54.84%
Net Profit (Loss) for the Period
60.85%
Total assets
50.55%
Total equity
45.77%
Operating Profit Margin (ROS)
2.21%
Net Profit Margin
2.53%
Return on Equity (ROE)
3.89%
Debt to Equity Ratio
13.37%
Quick Ratio
-0.04%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?